dow chemical said yesterday its firstquarter earnings would be lower than expected due to reduced earnings at marion merrell dow its prescription drugs subsidiary agencies report dow has a 71 per cent stake in marion merrell the us chemical company said its firstquarter pershare net income could be about 25 cents below the 62 cents of a year ago that figure was reached before onetime retiree healthcare charges including the charges dow lost dollars 217 a share in the period marion merrell said its firstquarter earnings could be as much as 60 to 70 per cent below average analysts expectations of 62 cents a share for the first quarter ended march 31 1992 marion merrell reported net income of 60 cents a share marion merrell said the expected firstquarter decline was mainly due to sharply lower us sales of its major prescription products compared with a the same period in the previous year